AzTrials
AzTrials

PCL - Posterior Cruciate Ligament DeficiencyNCT07575256

Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion Fractures

A study testing Surgical robot-assisted arthroscopic surgery and Open reduction and internal fixation surgery in people with PCL - Posterior Cruciate Ligament Deficiency and Posterior Cruciate Ligament Tear, run by Beijing Tsinghua Chang Gung Hospital at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The primary objective of this clinical trial is to evaluate the efficacy of robotic-assisted surgery in the management of posterior cruciate ligament (PCL) avulsion fractures involving the tibial insertion site of the cruciate ligament. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Surgical robot-assisted arthroscopic surgery and Open reduction and internal fixation surgery
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteChina
Study dates
10 May 2026to 31 Dec 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years
  • Acute closed tibial avulsion fracture, with surgery performed within 3 weeks of injury ③ Radiographically confirmed Meyers-McKeever classification Type II or III fracture ④ Absence of absolute contraindications to surgical intervention ⑤ Provision of voluntary, written informed consent prior to enrollment

Who cannot join

  • Pathological fractures or complex ipsilateral injuries, including concomitant fractures at other anatomical sites.
  • Prior ipsilateral knee joint surgery. ③. Significant vascular or neurological compromise.
  • Acute meniscal tears, acute anterior cruciate ligament (ACL) ruptures, or acute injuries to the medial or lateral collateral ligaments.
  • Compromised local soft tissue integrity, including open fractures. ⑥. Withdrawal from the study or loss to follow-up despite having provided written informed consent.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site
  • Beijing Tsinghua Changgung Hospital

    Beijing, Beijing Municipality, 102218

    Liu Kui, +8615932650850, liukui8153@sina.com

Other trials in China

About this study

The primary objective of this clinical trial is to evaluate the efficacy of robotic-assisted surgery in the management of posterior cruciate ligament (PCL) avulsion fractures involving the tibial insertion site of the cruciate ligament. Specifically, the study seeks to determine: (1) whether robotic-assisted surgery yields superior anatomical reduction accuracy-particularly in restoring the native position of the tibial avulsion fragment-compared with conventional open reduction and internal fixation (ORIF); and (2) whether such improved precision translates into enhanced long-term functional recovery of the knee joint.

Read the detailed description

Patients diagnosed with posterior cruciate ligament (PCL) tibial avulsion fractures-confirmed according to established radiographic and clinical diagnostic criteria-were prospectively enrolled from three geographically distinct regional medical centers. Prior to enrollment, all participants received comprehensive oral and written information detailing the study's objectives, methodology, potential risks and benefits, and the two comparative surgical interventions: robotic-assisted fixation and conventional open reduction and internal fixation (ORIF). Written informed consent was obtained from each participant following a mandatory reflection period and prior to randomization or any study-related procedures. All enrolled patients underwent standardized preoperative imaging, including anteroposterior and lateral radiographs of the knee, computed tomography (CT), and magnetic resonance imaging (MRI). Imaging interpretation was performed independently by two board-certified musculoskeletal radiologists blinded to group allocation; consensus adjudication resolved discrepancies. Radiological assessment confirmed diagnosis, classified fracture morphology using the Meyers-McKeever classification , and verified adherence to prespecified inclusion and exclusion criteria. Participants were then allocated in a 1:1 ratio to either the robotic-assisted surgery group (intervention group) or the ORIF group (control group) via centralized, stratified randomization-stratified by ageand fracture type . Baseline demographic, clinical, and functional assessments-including physical examination and validated patient-reported outcome measures (e.g., IKDC subjective score)-were completed preoperatively. All surgical procedures were performed by senior orthopedic surgeons with subspecialty expertise in knee trauma, either directly or under their immediate supervision, to ensure procedural fidelity and minimize interoperator variability. Primary and secondary outcomes were assessed at prespecified time points using objective, validated, and reproducible metrics. Radiographic evaluation of reduction accuracy entailed measurement of maximal sagittal displacement of the avulsed fragment on postoperative CT scans acquired within 72 ± 24 hours after surgery. The IKDC subjective score was collected at 24 weeks (±2 weeks) and 12 months (±1 month) postoperatively. Fracture union was determined radiologically using CT criteria and knee range of motion (ROM) was measured using a standard goniometer at 12 weeks (±1 week) and 24 weeks (±2 weeks). Intraoperative process metrics-including operative duration, intraoperative fluoroscopic exposure count, estimated blood loss (measured gravimetrically and volumetrically), and incidence of adverse events (e.g., surgical site infection, neurovascular injury, implant-related complications, or unplanned reoperation)-were systematically documented and compared between groups. Randomization was implemented using a computer-generated, permuted-block randomization sequence managed centrally and stratified as noted above. Statistical analyses adhered to a prespecified analysis plan: normality of continuous variables was assessed using the Shapiro-Wilk test; normally distributed data are presented as mean ± standard deviation and compared using independent-samples t-tests; non-normally distributed data are reported as median (interquartile range) and analyzed using the Mann-Whitney U test. Missing data were addressed via multiple imputation , followed by sensitivity analyses using complete-case and worst-case scenarios. Categorical variables are expressed as frequency (percentage) and compared using the chi-square test or Fisher's exact test, as appropriate.

Being tested
Surgical robot-assisted arthroscopic surgery, Open reduction and internal fixation surgery
Keywords
Posterior Cruciate Ligament tibial avulsion fractures, Robot-assisted surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Surgical robot-assisted arthroscopic surgeryProcedure or surgery

    Experimental group: Robot-assisted arthroscopic surgery

  • Open reduction and internal fixation surgeryProcedure or surgery

    Control group: incisional reduction and internal fixation surgery

Study groups in NCT07575256
Study groupRoleWhat they receive
Experimental groupActive comparatorPerform surgical robot-assisted arthroscopic surgery
Receives: Procedure: Surgical robot-assisted arthroscopic surgery
Control groupOtherTraditional posterior incision reduction and internal fixation surgery is performed
Receives: Procedure: Open reduction and internal fixation surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the quality of surgical reduction

    In the CT scan images obtained approximately 72 hours (±24 hours) after the surgery, the maximum distance between the fracture fragments was measured on the sagittal plane.

    Measured: 72 hours (±24 hours) after the surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2026
  2. Study start10 May 2026 (estimated)
  3. Primary completion31 Dec 2030 (estimated)
  4. Study completion31 Dec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Group A: Robot-assisted surgery group (experimental group) Group B: Open reduction and internal fixation group (control group)
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
22 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07575256
Sponsor's protocol ID
26490-4-01
Status last verified
May 2026
First submitted
12 Apr 2026
Last updated
8 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The original dataset will be made available to the collaborating research team no later than 12 months following the completion of the clinical trial. Subsequently, de-identified data will be shared via a secure, encrypted transmission protocol. Any use of the data is strictly contingent upon prior written approval from the principal investigator and formal authorization by the institutional ethics review board, and shall be limited exclusively to peer-reviewed scientific research activities.

Questions about this trial

What is this clinical trial studying?

A study testing Surgical robot-assisted arthroscopic surgery and Open reduction and internal fixation surgery in people with PCL - Posterior Cruciate Ligament Deficiency and Posterior Cruciate Ligament Tear, run by Beijing Tsinghua Chang Gung Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yu Jia-kuo, MD,Phd (+86 133 3103 1448, yujiakuo@tsinghua.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the quality of surgical reduction (time frame: 72 hours (±24 hours) after the surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in